Pilot Study of DHA-EE

We are please to announce IRB (Independent Review Board) approval of our pilot DHA-EE study, June 2016!

Our first study is a single-center non-placebo controlled observational study evaluating the effects of daily MAMA DHA-EE supplementation in subjects with Autism Spectrum Disorder, Peroxisomal Biogenesis Disorder, or Mitochondrial Disorder.

The study is run by Integra Research Center.